1111

Vitamin D and cardiovascular disease: update and outlook..作者:Pilz S; Kienreich K; Tomaschitz A; Lerchbaum E; Meinitzer A; März W; Zittermann A; Dekker JM.
作者地址:Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria. stefan.pilz@chello.at.
来源:[Scand J Clin Lab Invest Suppl] Scandinavian Journal Of Clinical And Laboratory Investigation. Supplementum 2012 Apr; Vol. 243, pp. 83-91. .
出版物类型:Journal Article; Review.
语言:English.
Journal Information:Publisher: Blackwell Scientific : Oslo Country of Publication: England NLM ID: 2984789R Publication Model: Print Cited Medium: Internet ISSN: 0085-591X (Print) Linking ISSN: 0085591X NLM ISO Abbreviation: Scand. J. Clin. Lab. Invest. Suppl. Subsets: MEDLINE.
MeSH 词语:Cardiovascular Diseases/*etiology
Vitamin D Deficiency/*complications
Animals ; Cardiovascular Diseases/prevention & control ; Dietary Supplements ; Humans ; Mice ; Rats ; Receptors, Calcitriol/physiology ; Risk Factors ; Vitamin D/administration & dosage ; Vitamin D/analogs & derivatives ; Vitamin D/blood.
摘要:Accumulating evidence suggests that vitamin D may play a role for cardiovascular health. Expression of the vitamin D receptor (VDR) and enzymes for vitamin D metabolism have been identified in the vasculature as well as in the heart. VDR knock-out mice suffer from cardiovascular disease (CVD) and even selective VDR deletion in cardiomyocytes causes myocardial hypertrophy. Many, but not all observational studies showed that vitamin D deficiency is associated with CVD and its risk factors. Low concentrations of 25-hydroxyvitamin D (25(OH)D) are an independent risk factor for cardiovascular events, in particular for strokes and sudden cardiac deaths. Only few randomized controlled trials (RCTs) are available on this topic. These RCTs are frequently limited by the additional supplementation of calcium which may increase the risk of CVD events. RCTs with pure vitamin D supplementation have partially but not consistently shown beneficial effects on cardiovascular risk factors such as arterial hypertension. A number of large RCTs on the impact of vitamin D supplementation on cardiovascular events and mortality have already started but limitations of the study designs such as inclusion of individuals with relatively high 25(OH)D concentrations have to be considered. At present, the evidence is not sufficient for general recommendations to supplement vitamin D in order to prevent and treat CVD. It should, however, be noted that justification for the prevention and treatment of vitamin D deficiency comes from evidence based benefits of vitamin D supplementation on musculoskeletal health..
物质命名法:0 (Receptors, Calcitriol)
1406-16-2 (Vitamin D)
64719-49-9 (25-hydroxyvitamin D).


只有摘要，没找到全文，抱歉了。

这篇文献太新了。

打开网页 我只看到了摘要 不要意思 没帮到你。。